Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Sonos
SONO
$1.96B
| $3.39M | ﹤0.01% |
317,555
-53,059
| -14% | -$697K |
|
2202
Helmerich & Payne
HP
$4.3B
| $3.39M | ﹤0.01% |
129,664
-47,368
| -27% | -$1.38M |
|
|
WNS
2203
DELISTED
WNS Holdings
WNS
| $3.38M | ﹤0.01% |
54,963
-21,476
| -28% | -$1.22M |
|
2204
Renasant Corp
RNST
$4B
| $3.36M | ﹤0.01% |
99,030
-48,813
| -33% | -$1.77M |
|
2205
NextNav
NN
$3.29B
| $3.36M | ﹤0.01% |
276,042
+142,752
| +107% | +$1.72M |
|
2206
Integra LifeSciences
IART
$1.42B
| $3.35M | ﹤0.01% |
152,517
-32,507
| -18% | -$764K |
|
2207
Main Street Capital
MAIN
$5.54B
| $3.35M | ﹤0.01% |
59,285
+17,123
| +41% | +$1.02M |
|
2208
Sweetgreen
SG
$721M
| $3.35M | ﹤0.01% |
133,863
-71,308
| -35% | -$1.97M |
|
2209
Standard BioTools
LAB
$294M
| $3.35M | ﹤0.01% |
3,100,539
-130,312
| -4% | -$183K |
|
2210
Central Garden & Pet Co Class A
CENTA
$2.41B
| $3.34M | ﹤0.01% |
102,097
-22,676
| -18% | -$720K |
|
2211
Wingstop
WING
$3.1B
| $3.34M | ﹤0.01% |
14,805
-186,653
| -93% | -$48.5M |
|
2212
CALL
DigitalOcean
DOCN
$15.6B
| $3.34M | ﹤0.01% |
+100,000
| New | +$3.91M |
|
|
EU
2213
enCore Energy
EU
$221M
| $3.34M | ﹤0.01% |
2,435,098
+2,080,909
| +588% | +$5.35M |
|
2214
Hawkins
HWKN
$2.67B
| $3.33M | ﹤0.01% |
31,443
-10,279
| -25% | -$1.13M |
|
2215
Agios Pharmaceuticals
AGIO
$2B
| $3.32M | ﹤0.01% |
113,153
-8,600
| -7% | -$285K |
|
2216
ScottsMiracle-Gro
SMG
$3.59B
| $3.3M | ﹤0.01% |
60,120
+14,220
| +31% | +$919K |
|
2217
Flowers Foods
FLO
$1.6B
| $3.3M | ﹤0.01% |
173,493
-4,588
| -3% | -$87.7K |
|
|
BOW
2218
Bowhead Specialty Holdings
BOW
$1.1B
| $3.3M | ﹤0.01% |
81,082
+22,739
| +39% | +$774K |
|
|
PPBI
2219
DELISTED
Pacific Premier Bancorp
PPBI
| $3.29M | ﹤0.01% |
154,546
-57,074
| -27% | -$1.36M |
|
2220
Genco Shipping & Trading
GNK
$1.13B
| $3.29M | ﹤0.01% |
246,596
-36,007
| -13% | -$511K |
|
|
NGD
2221
DELISTED
New Gold Inc
NGD
| $3.29M | ﹤0.01% |
887,662
-36,218
| -4% | -$107K |
|
2222
Trinity Industries
TRN
$2.34B
| $3.29M | ﹤0.01% |
117,176
-55,758
| -32% | -$1.87M |
|
2223
Advance Auto Parts
AAP
$3.46B
| $3.28M | ﹤0.01% |
83,735
-210,330
| -72% | -$9.02M |
|
2224
Grand Canyon Education
LOPE
$3.79B
| $3.28M | ﹤0.01% |
18,972
-28,905
| -60% | -$5.02M |
|
2225
Sabre
SABR
$892M
| $3.28M | ﹤0.01% |
1,167,685
+318,932
| +38% | +$1.13M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.